Non-surgical Ablation Therapy for Early-stage Breast Cancer

CHF 190.85
Auf Lager
SKU
MTG9MU7JLKS
Stock 1 Verfügbar
Geliefert zwischen Mi., 26.11.2025 und Do., 27.11.2025

Details

This book offers an extensive discussion of breast-conserving treatment, including radiofrequency ablation (RFA), cryoablation and focused ultrasound surgery. It examines the future development of non-surgical ablation of breast cancer.

Covering the history of breast cancer, theory of radiofrequency ablation (RFA), resection of carcinoma, imaging before and after non-surgical ablation therapy and quality of life, this book focuses on extensive breast-conserving treatment for the preservation of a cosmetically acceptable breast. It investigates the feasibility of percutaneous, minimally invasive techniques to ablate breast tumors and several modalities such as cryosurgery, laser ablation, thermoablation and high-intensity focused ultrasound. Non-surgical Ablation Therapy for Early-stage Breast Cancer centers on RFA and provides insights into cryoablation and focused ultrasound surgery.
RFA has been shown to be effective for treating tumors in many types of tissue, including liver, bone, brain, kidney, pancreas and prostate. As such this book is a valuable resource for breast and general surgeons, radiation oncologists and medical oncologists in all areas. The extensive discussions enable scholars to gain radiological expertise and a basic understanding of molecular biology, leading to better surgery without scalpels.


Presents the history of breast cancer, theory of RFA, resection of carcinoma, imaging before and after non-surgical ablation therapy and QOL. Extensively discusses breast-conserving treatment, including radiofrequency ablation (RFA), cryoablation and focused ultrasound surgery Discusses new trends and advances in breast cancer surgery and the future development of non-surgical ablation of breast cancer Includes supplementary material: sn.pub/extras

Autorentext
Takayuki Kinoshita, M.D, Ph.D Chief, Division of Breast Surgery National Cancer Center Hospital, Chuo-ku, Tokyo, Japa

Inhalt
1 Introduction.-2 Evolution of Operative Methods in Japan.-3 New Trends and Development in Breast Surgery.-4 A Theory of Radiofrequency Ablation (RFA).-5 RFA of Breast Cancer; Criteria and Procedure.-6 RFA of Breast Cancer; Technique1: Requisite Skills; Pitfalls to Avoid.-7 RFA of Breast Cancer; Technique2: Knack and pitfall.-8 Histopathological Evaluation of the Therapeutic Effect of RFA for Early Breast Cancer.-9 Importance of Breast Imaging Before and After RFA Therapy.-10 Cosmetic Outcome and QOL.-11 RFA of Breast Cancer: a Multicenter Retrospective Analysis.-12 RFA with a Cool-tip Electrode in Early Breast Cancer.-13 RFA with a LeVeen Needle Electrode in Early Breast Cancer.-14 RFA of Early Breast Cancer Followed by Delayed Surgical Resection.-15 RFA of Early Breast Cancer without Resection.-16 Prospective Study of RFA of Early Breast Cancer without Resection.-17 MRI-guided Focused Ultrasound Surgery of Breast Cancer.-18 Ultrasonography Guided Non-surgical Cryoablation for Small Breast Cancer.-19 Importance of Breast Imaging before and after Non-surgical Ablation Therapy.-20 Future and Development of Non-surgical Ablation of Breast Cancer.

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Editor Takayuki Kinoshita
    • Titel Non-surgical Ablation Therapy for Early-stage Breast Cancer
    • Veröffentlichung 07.06.2018
    • ISBN 4431566295
    • Format Kartonierter Einband
    • EAN 9784431566298
    • Jahr 2018
    • Größe H235mm x B155mm x T12mm
    • Gewicht 401g
    • Auflage Softcover reprint of the original 1st edition 2016
    • Genre Medizin
    • Lesemotiv Verstehen
    • Anzahl Seiten 232
    • Herausgeber Springer
    • GTIN 09784431566298

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470